SOSV

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Bloomlife is a pioneering women's health company focused on enhancing maternal care through innovative technology. By integrating connected devices with cloud-based data analytics, Bloomlife aims to improve access to care for expectant mothers and empower them with crucial information. The company's remote maternal care platform facilitates the monitoring of high-risk pregnancies, allowing obstetricians to better assess maternal and fetal risks and educate patients effectively. Bloomlife’s solutions reduce the need for frequent in-person appointments and lengthy referral processes, thus streamlining the management of pregnancy complications. With a commitment to redefining maternal health, Bloomlife seeks to become the leading provider of remote care for expectant women worldwide, ultimately improving health outcomes for mothers and babies.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

FreeD Group is a technology company based in Lai Chi Kok, Hong Kong, founded in 2015. It specializes in providing a text-based virtual assistant service that offers travel information and concierge services for travelers in Korea and Japan. The company facilitates various travel-related activities, including flight and hotel bookings, trip planning, restaurant reservations, translation, and transportation services, all accessible through popular messaging platforms like WhatsApp and Facebook Messenger. Additionally, FreeD Group develops AI-enabled solutions that enhance customer engagement, retention, and monetization for businesses. By utilizing advanced technologies such as Artificial Intelligence, Big Data, and Machine Learning, the company aims to create innovative, data-driven interactions between consumers and brands. Its partnerships with notable companies, including China Mobile and Samsung, further bolster its market presence.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

InfiniteUp is a Canadian AI startup based in Nanaimo, British Columbia, focused on empowering small and medium-sized enterprises (SMEs) through its flagship platform, DOER Business. Launched in 2020, DOER Business serves as an all-in-one AI-powered virtual business partner, offering accessible enterprise-grade productivity tools. The platform features AI-driven strategic briefings, automated task management, intelligent sales recommendations, and digital employee “twins” to enhance operational efficiency. With a user-friendly design, InfiniteUp makes advanced generative AI technology easy to use for everyday businesses. Key offerings include a Digital COO, CEO Daily Briefing, voice command capabilities, CRM tools, and localized support, making it adaptable across various industries. In addition to its scalable SaaS product, InfiniteUp operates a revenue-generating app development agency, allowing for sustainable early revenue while driving the growth of its core platform. With strategic partnerships in emerging markets and a globally distributed team, InfiniteUp is positioned to transform how SMEs leverage AI in their operations.

InfiniteUp is a Canadian AI startup based in Nanaimo, British Columbia, focused on empowering small and medium-sized enterprises (SMEs) through its flagship platform, DOER Business. Launched in 2020, DOER Business serves as an all-in-one AI-powered virtual business partner, offering accessible enterprise-grade productivity tools. The platform features AI-driven strategic briefings, automated task management, intelligent sales recommendations, and digital employee “twins” to enhance operational efficiency. With a user-friendly design, InfiniteUp makes advanced generative AI technology easy to use for everyday businesses. Key offerings include a Digital COO, CEO Daily Briefing, voice command capabilities, CRM tools, and localized support, making it adaptable across various industries. In addition to its scalable SaaS product, InfiniteUp operates a revenue-generating app development agency, allowing for sustainable early revenue while driving the growth of its core platform. With strategic partnerships in emerging markets and a globally distributed team, InfiniteUp is positioned to transform how SMEs leverage AI in their operations.

Inso Biosciences is an early-stage biotechnology company focused on developing innovative hardware platforms and tools for genomic sample handling. Utilizing patented microfluidic technology originally invented at Cornell University, Inso Biosciences enhances the efficiency of processing cellular material. The company's platform is designed to facilitate genomic analysis, including applications in long-read DNA extraction, multiomic sample processing, and pathogen surveillance. By enabling healthcare and biotechnology companies to effectively separate and isolate cellular components, Inso Biosciences aims to transform the landscape of biological sample preparation.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Dataforge.ai specializes in data annotation services for artificial intelligence and machine learning applications. The company offers a platform that facilitates the training of AI models through precise image annotation, ensuring high accuracy while maintaining low costs. By leveraging machine learning technology, Dataforge.ai assists AI teams in addressing various data challenges, including storage, collection, cleaning, and labeling of data. This comprehensive approach enables clients to expedite their processes and enhance operational efficiency.

Dataforge.ai specializes in data annotation services for artificial intelligence and machine learning applications. The company offers a platform that facilitates the training of AI models through precise image annotation, ensuring high accuracy while maintaining low costs. By leveraging machine learning technology, Dataforge.ai assists AI teams in addressing various data challenges, including storage, collection, cleaning, and labeling of data. This comprehensive approach enables clients to expedite their processes and enhance operational efficiency.

BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.

Our AI-powered business intelligence model, provides analysis, predictions, and optimizations that drive our fully integrated e-commerce and digital marketing multiplatform operations for global brands.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Journey Foods is a machine learning-driven software platform that serves the packaged food industry, focusing on enhancing product monitoring and development for consumer packaged goods companies, ingredient suppliers, and manufacturers. The company offers enterprise technology designed to streamline innovation and decision-making, enabling food companies to efficiently transition from concept to commercialization. Journey Foods' software provides tools for configuring consumer preferences, generating optimized product formulations, and delivering automated insights on compliance, nutrition, and sustainability. With a robust database containing over 1 billion ingredient insights, Journey Foods utilizes advanced algorithms to offer dynamic analysis and optimized portfolio recommendations based on pricing, supply chain, and nutrition parameters. The platform supports management teams in making informed strategic decisions and facilitates the monitoring of products within the expansive $3 trillion packaged foods market, ultimately improving nutrition, cost efficiency, and sustainability across product lines.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.

Lootcakes Inc. is a New York-based company founded in 2012 that provides an online platform focused on gaming data, particularly for free-to-play games. The platform allows players to consolidate their gaming activity and social engagement across different platforms. By utilizing in-game purchasing and social data, Lootcakes connects high-value players—those who spend money and engage socially with others—to game publishers. This connection is essential as game publishers increasingly rely on these players, who drive revenue and attract new users through their social interactions. Lootcakes aims to empower gamers by helping them unlock the value of their game activity data, enabling them to benefit from their influence within the gaming community.

CITYDATA.ai is a developer of a geospatial artificial intelligence platform that simulates the presence and movement of people across 9,000 cities globally. The company utilizes location intelligence to create mobility digital replicas, which quantify population counts and analyze movement patterns. Its platform integrates various products designed to enhance community engagement and data collection, including CITYCOUNT.ai, CITYPARKS.ai, CITYFLOW.ai, CITYSIM.ai, CITYOPS.ai, CITYSURVEY.ai, CITYCHAT.ai, and CITYSDK.ai. These tools enable the collection of mobility data from both public and private sources, facilitating on-site surveys, improving field workforce productivity, and helping brands connect with targeted audiences. Through its citizen apps and chatbots, CITYDATA.ai actively engages residents, providing them with contextual data relevant to their cities while measuring foot traffic and advertising effectiveness.

Our AI-powered business intelligence model, provides analysis, predictions, and optimizations that drive our fully integrated e-commerce and digital marketing multiplatform operations for global brands.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

FreeD Group is a technology company based in Lai Chi Kok, Hong Kong, founded in 2015. It specializes in providing a text-based virtual assistant service that offers travel information and concierge services for travelers in Korea and Japan. The company facilitates various travel-related activities, including flight and hotel bookings, trip planning, restaurant reservations, translation, and transportation services, all accessible through popular messaging platforms like WhatsApp and Facebook Messenger. Additionally, FreeD Group develops AI-enabled solutions that enhance customer engagement, retention, and monetization for businesses. By utilizing advanced technologies such as Artificial Intelligence, Big Data, and Machine Learning, the company aims to create innovative, data-driven interactions between consumers and brands. Its partnerships with notable companies, including China Mobile and Samsung, further bolster its market presence.

Journey Foods is a machine learning-driven software platform that serves the packaged food industry, focusing on enhancing product monitoring and development for consumer packaged goods companies, ingredient suppliers, and manufacturers. The company offers enterprise technology designed to streamline innovation and decision-making, enabling food companies to efficiently transition from concept to commercialization. Journey Foods' software provides tools for configuring consumer preferences, generating optimized product formulations, and delivering automated insights on compliance, nutrition, and sustainability. With a robust database containing over 1 billion ingredient insights, Journey Foods utilizes advanced algorithms to offer dynamic analysis and optimized portfolio recommendations based on pricing, supply chain, and nutrition parameters. The platform supports management teams in making informed strategic decisions and facilitates the monitoring of products within the expansive $3 trillion packaged foods market, ultimately improving nutrition, cost efficiency, and sustainability across product lines.

BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.

BiomeSense, Inc. is a Chicago-based company founded in 2018 that focuses on developing a comprehensive platform for microbiome data collection and analysis. Its primary innovation is the GutLab, a "smart bathroom" system designed for continuous, at-home monitoring of the human gut microbiome. This technology is integrated with the MetaBiome time-series analytics platform, offering a seamless end-to-end solution that enables real-time tracking of microbiome changes and their correlation with clinical outcomes. By generating and analyzing extensive longitudinal microbiome datasets, BiomeSense aims to discover and commercialize novel microbiome biomarkers, providing healthcare professionals with a high-resolution microbiome database. This resource supports the development of advanced microbiome-based therapeutics and consumer products, ultimately enhancing precision medicine and improving health outcomes.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

AWB Health, founded in 2012, is a leading workplace wellness company that offers a comprehensive digital platform focused on nutrition, medical care, fitness, emotional well-being, and environmental health. The company aims to help employees develop healthy work-life habits through goal setting and personalized health reports generated from health risk assessments. In addition to its online offerings, AWB Health organizes various engaging offline events to further promote wellness. The platform provides a range of services, including health risk assessments, customized health programs, nutritional advice, and responses to health-related inquiries, enabling users to maintain their fitness and health effectively. AWB Health also generates group health reports using big data analytics, which assist companies in designing effective wellness programs that enhance employee engagement and productivity. The company serves a diverse clientele, including several Fortune 500 companies such as Disney, Roche, and Adidas.

Quartolio Inc. is a technology company founded in 2016 and based in Long Island, New York, that specializes in developing an AI-powered platform for research management. The platform is designed to synthesize insights from vast amounts of scientific data, enabling users to connect, discover, and manage research efficiently. Utilizing advanced natural language processing, Quartolio’s autonomous insight discovery platform provides real-time analysis of millions of scientific documents, facilitating streamlined research across various disciplines. This innovative approach allows clients to enhance their research capabilities by uncovering connections among scientific articles, clinical trials, and patents.

Robin8 is a next-generation social and content marketing platform that leverages artificial intelligence to streamline outreach to reporters and influencers. By continuously tracking and analyzing vast amounts of data from billions of articles, Robin8 curates a comprehensive database of influencers tailored to individual user profiles. The platform employs machine learning and big data to enhance its recommendations, adapting to user preferences over time. This intelligence simplifies public relations efforts, transforming them into a straightforward, four-step process. Additionally, Robin8 facilitates the uploading and monetization of digital assets on the blockchain, providing clients with the tools needed to optimize their social media profiles and other digital resources effectively.

LOTaDATA, Inc. is a company that specializes in mobile location insights and predictive analytics solutions, utilizing machine learning to cater to apps, cities, and businesses both domestically and internationally. Founded in 2014 and headquartered in San Francisco, California, with additional locations in London and Porto Alegre, the company curates geospatial data sets that combine public and private information. Their platform provides business intelligence by delivering location-based insights that help enterprise businesses, smart cities, service providers, and marketers understand user behavior and engagement with various community facilities and services. LOTaDATA analyzes data related to attendance, demographics, and social interactions, offering deep insights into public usage patterns and enabling clients to make informed decisions based on historical and real-time data regarding people's activities and interactions within their environments.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

AWB Health, founded in 2012, is a leading workplace wellness company that offers a comprehensive digital platform focused on nutrition, medical care, fitness, emotional well-being, and environmental health. The company aims to help employees develop healthy work-life habits through goal setting and personalized health reports generated from health risk assessments. In addition to its online offerings, AWB Health organizes various engaging offline events to further promote wellness. The platform provides a range of services, including health risk assessments, customized health programs, nutritional advice, and responses to health-related inquiries, enabling users to maintain their fitness and health effectively. AWB Health also generates group health reports using big data analytics, which assist companies in designing effective wellness programs that enhance employee engagement and productivity. The company serves a diverse clientele, including several Fortune 500 companies such as Disney, Roche, and Adidas.

Bloomlife is a pioneering women's health company focused on enhancing maternal care through innovative technology. By integrating connected devices with cloud-based data analytics, Bloomlife aims to improve access to care for expectant mothers and empower them with crucial information. The company's remote maternal care platform facilitates the monitoring of high-risk pregnancies, allowing obstetricians to better assess maternal and fetal risks and educate patients effectively. Bloomlife’s solutions reduce the need for frequent in-person appointments and lengthy referral processes, thus streamlining the management of pregnancy complications. With a commitment to redefining maternal health, Bloomlife seeks to become the leading provider of remote care for expectant women worldwide, ultimately improving health outcomes for mothers and babies.

FreeD Group is a technology company based in Lai Chi Kok, Hong Kong, founded in 2015. It specializes in providing a text-based virtual assistant service that offers travel information and concierge services for travelers in Korea and Japan. The company facilitates various travel-related activities, including flight and hotel bookings, trip planning, restaurant reservations, translation, and transportation services, all accessible through popular messaging platforms like WhatsApp and Facebook Messenger. Additionally, FreeD Group develops AI-enabled solutions that enhance customer engagement, retention, and monetization for businesses. By utilizing advanced technologies such as Artificial Intelligence, Big Data, and Machine Learning, the company aims to create innovative, data-driven interactions between consumers and brands. Its partnerships with notable companies, including China Mobile and Samsung, further bolster its market presence.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Lootcakes Inc. is a New York-based company founded in 2012 that provides an online platform focused on gaming data, particularly for free-to-play games. The platform allows players to consolidate their gaming activity and social engagement across different platforms. By utilizing in-game purchasing and social data, Lootcakes connects high-value players—those who spend money and engage socially with others—to game publishers. This connection is essential as game publishers increasingly rely on these players, who drive revenue and attract new users through their social interactions. Lootcakes aims to empower gamers by helping them unlock the value of their game activity data, enabling them to benefit from their influence within the gaming community.

Steering AI Technologies Co. Ltd is a company focused on developing hardware and software solutions for autonomous driving. Founded in 2017 and headquartered in Xi'an, China, it specializes in creating innovative products such as a smart steering box that monitors driver fatigue and an intelligent steering wheel cover that recognizes both steering motion and drivers' physiological features. Additionally, Steering AI offers a vehicle network cloud platform and a big-data management service designed to enhance fleet safety by monitoring driving behaviors. The company's emphasis on wearable technology and intelligent systems aims to provide early warning systems for fatigue driving, thereby ensuring the safety of drivers on the road.

BoosterAgro, founded in 2016 and based in Buenos Aires, Argentina, is a leading digital platform for agricultural producers in South America. The company provides an app that helps farmers make informed decisions by offering tools and content related to weather forecasts, precipitation, crop health, satellite imagery, smart spraying, and seasonal insights. With over 80,000 users across major agricultural countries including Argentina, Brazil, Uruguay, Paraguay, and Bolivia, BoosterAgro serves as a vital resource for farmers seeking to enhance efficiency and productivity. The platform allows users to access valuable information on demand via mobile devices and also facilitates direct connections between farmers and local suppliers, ensuring that users can easily find products and services tailored to their specific farming needs.

CITYDATA.ai is a developer of a geospatial artificial intelligence platform that simulates the presence and movement of people across 9,000 cities globally. The company utilizes location intelligence to create mobility digital replicas, which quantify population counts and analyze movement patterns. Its platform integrates various products designed to enhance community engagement and data collection, including CITYCOUNT.ai, CITYPARKS.ai, CITYFLOW.ai, CITYSIM.ai, CITYOPS.ai, CITYSURVEY.ai, CITYCHAT.ai, and CITYSDK.ai. These tools enable the collection of mobility data from both public and private sources, facilitating on-site surveys, improving field workforce productivity, and helping brands connect with targeted audiences. Through its citizen apps and chatbots, CITYDATA.ai actively engages residents, providing them with contextual data relevant to their cities while measuring foot traffic and advertising effectiveness.

LOTaDATA, Inc. is a company that specializes in mobile location insights and predictive analytics solutions, utilizing machine learning to cater to apps, cities, and businesses both domestically and internationally. Founded in 2014 and headquartered in San Francisco, California, with additional locations in London and Porto Alegre, the company curates geospatial data sets that combine public and private information. Their platform provides business intelligence by delivering location-based insights that help enterprise businesses, smart cities, service providers, and marketers understand user behavior and engagement with various community facilities and services. LOTaDATA analyzes data related to attendance, demographics, and social interactions, offering deep insights into public usage patterns and enabling clients to make informed decisions based on historical and real-time data regarding people's activities and interactions within their environments.

Bloomlife is a pioneering women's health company focused on enhancing maternal care through innovative technology. By integrating connected devices with cloud-based data analytics, Bloomlife aims to improve access to care for expectant mothers and empower them with crucial information. The company's remote maternal care platform facilitates the monitoring of high-risk pregnancies, allowing obstetricians to better assess maternal and fetal risks and educate patients effectively. Bloomlife’s solutions reduce the need for frequent in-person appointments and lengthy referral processes, thus streamlining the management of pregnancy complications. With a commitment to redefining maternal health, Bloomlife seeks to become the leading provider of remote care for expectant women worldwide, ultimately improving health outcomes for mothers and babies.

Girihlet Inc. is a genetic-sequencing company based in Oakland, California, founded in 2012. It specializes in providing rapid and accurate deep sequencing services, focusing on T cell receptor profiling and mitochondrial DNA analysis. Utilizing novel, bias-free methods, Girihlet aims to harness these genomic insights as biomarkers for diagnostics across various disorders, particularly those related to T-cell-driven autoimmune conditions. The company employs advanced sequencing technologies combined with machine learning to decode immune responses, thereby informing appropriate therapeutic strategies. Through its innovative approach, Girihlet seeks to enhance diagnostic capabilities and support researchers in advancing basic research in immunology.

Truust Neuroimaging, Inc. specializes in advanced data analysis services for brain research. Established in 2015 and located in San Francisco, California, the company processes and analyzes existing data collected by clients, including multi-electrode array (MEA), electroencephalography (EEG), and electrocorticography (ECOG) data. Truust Neuroimaging enhances the resolution of neuro-imaging systems, significantly improving the ability to diagnose and treat brain-related conditions such as epilepsy and neurodegenerative diseases like Alzheimer's and Parkinson's. The company also provides analysis services for applications in virtual reality, neurostimulation, neuromarketing, and consumer testing. By increasing neuro-imaging resolution, Truust enables researchers and clinicians to make new discoveries and advance technologies such as brain-computer interfaces and augmented cognition.

Girihlet Inc. is a genetic-sequencing company based in Oakland, California, founded in 2012. It specializes in providing rapid and accurate deep sequencing services, focusing on T cell receptor profiling and mitochondrial DNA analysis. Utilizing novel, bias-free methods, Girihlet aims to harness these genomic insights as biomarkers for diagnostics across various disorders, particularly those related to T-cell-driven autoimmune conditions. The company employs advanced sequencing technologies combined with machine learning to decode immune responses, thereby informing appropriate therapeutic strategies. Through its innovative approach, Girihlet seeks to enhance diagnostic capabilities and support researchers in advancing basic research in immunology.

Robin8 is a next-generation social and content marketing platform that leverages artificial intelligence to streamline outreach to reporters and influencers. By continuously tracking and analyzing vast amounts of data from billions of articles, Robin8 curates a comprehensive database of influencers tailored to individual user profiles. The platform employs machine learning and big data to enhance its recommendations, adapting to user preferences over time. This intelligence simplifies public relations efforts, transforming them into a straightforward, four-step process. Additionally, Robin8 facilitates the uploading and monetization of digital assets on the blockchain, providing clients with the tools needed to optimize their social media profiles and other digital resources effectively.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Darma Inc. is a health technology company based in the United States that specializes in non-invasive health monitoring solutions. The company has developed an innovative non-wearable health tracking device known as the DARMA cushion, which allows users to monitor their vital signs through an integrated application while seated. This cushion not only provides real-time data on stress levels, sitting time, and posture but also offers reminders and alerts to encourage users to stand up and improve their posture. Additionally, Darma's technology includes advanced fiber optic biosensors designed for placement under mattresses, facilitating continuous monitoring of vital signs and cardiac performance without direct contact. By combining bio-sensing technology with cloud-based algorithms and healthcare management services, Darma aims to assist patients, caregivers, and healthcare providers in proactive health management, reducing hospital readmissions, and enhancing overall quality of life.

Darma Inc. is a health technology company based in the United States that specializes in non-invasive health monitoring solutions. The company has developed an innovative non-wearable health tracking device known as the DARMA cushion, which allows users to monitor their vital signs through an integrated application while seated. This cushion not only provides real-time data on stress levels, sitting time, and posture but also offers reminders and alerts to encourage users to stand up and improve their posture. Additionally, Darma's technology includes advanced fiber optic biosensors designed for placement under mattresses, facilitating continuous monitoring of vital signs and cardiac performance without direct contact. By combining bio-sensing technology with cloud-based algorithms and healthcare management services, Darma aims to assist patients, caregivers, and healthcare providers in proactive health management, reducing hospital readmissions, and enhancing overall quality of life.